Cargando…
Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction
AIM: Transthyretin cardiac amyloidosis (ATTR-CA) is an increasingly recognized cause of heart failure (HF) with preserved left ventricular ejection fraction (LVEF), typically presenting as restrictive cardiomyopathy. The potential co-existence of ATTR-CA with systolic heart failure has not been stud...
Autores principales: | Goland, Sorel, Volodarsky, Igor, Fabricant, Yacov, Livschitz, Shay, Tshori, Sagi, Cuciuc, Valeri, Zilberman, Liaz, Fugenfirov, Irena, Meledin, Valeri, Shimoni, Sara, Josfberg, Sagie, George, Jacob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270434/ https://www.ncbi.nlm.nih.gov/pubmed/34242301 http://dx.doi.org/10.1371/journal.pone.0254104 |
Ejemplares similares
-
Transthyretin cardiac amyloidosis in patients after TAVR: clinical and echocardiographic findings and long term survival
por: Shimoni, Sara, et al.
Publicado: (2021) -
Residual alterations of cardiac and endothelial function in patients who recovered from Takotsubo cardiomyopathy
por: Zilberman, Liaz, et al.
Publicado: (2021) -
Elevated Serum Levels of IgG4 in Patients with Heart Failure with Reduced Ejection Fraction: A Prospective Controlled Study
por: Volodarsky, Igor, et al.
Publicado: (2022) -
Circulating Soluble TREM2 and Cardiovascular Outcome in Cohort Study of Coronary Atherosclerosis Patients
por: Cuciuc, Valeri, et al.
Publicado: (2022) -
Subclinical Myocardial Dysfunction in Patients Recovered from COVID-19 Disease: Correlation with Exercise Capacity
por: Shimoni, Or, et al.
Publicado: (2021)